Literature DB >> 8177743

Kappa immunoglobulin promoters and enhancers display developmentally controlled interactions.

R Fulton1, B Van Ness.   

Abstract

We have investigated the interaction of the kappa immunoglobulin light chain intron and 3' enhancers with two different kappa promoters at distinct stages of B-cell development. We find that transiently transfected reporter gene constructs driven by either the kappa V-region promoter, or the kappa germline promoter, are controlled by the known enhancers of the locus in a developmentally regulated fashion. We have, however, observed differences in promoter activation by each enhancer. Moreover, constructs controlled by a combination of both enhancers are synergistically activated at the B-cell and plasma cell stages as compared with constructs containing either enhancer alone. This synergy is not observed early in development, at the pre-B cell stage. The pattern of enhancer and promoter interactions is discussed in the context of the known developmental regulation of the locus.

Mesh:

Substances:

Year:  1993        PMID: 8177743      PMCID: PMC311410          DOI: 10.1093/nar/21.21.4941

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  35 in total

1.  A novel B cell-derived coactivator potentiates the activation of immunoglobulin promoters by octamer-binding transcription factors.

Authors:  Y Luo; H Fujii; T Gerster; R G Roeder
Journal:  Cell       Date:  1992-10-16       Impact factor: 41.582

2.  The role of the kappa enhancer and its binding factor NF-kappa B in the developmental regulation of kappa gene transcription.

Authors:  M L Atchison; R P Perry
Journal:  Cell       Date:  1987-01-16       Impact factor: 41.582

3.  Transcriptional control of mu- and kappa-gene expression in resting and bacterial lipopolysaccharide-activated normal B cells.

Authors:  U Chen-Bettecken; E Wecker; A Schimpl
Journal:  Immunobiology       Date:  1987-03       Impact factor: 3.144

4.  Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites.

Authors:  P N Cockerill; W T Garrard
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

5.  The immunoglobulin octanucleotide: independent activity and selective interaction with enhancers.

Authors:  T G Parslow; S D Jones; B Bond; K R Yamamoto
Journal:  Science       Date:  1987-03-20       Impact factor: 47.728

6.  An octamer oligonucleotide upstream of a TATA motif is sufficient for lymphoid-specific promoter activity.

Authors:  T Wirth; L Staudt; D Baltimore
Journal:  Nature       Date:  1987 Sep 10-16       Impact factor: 49.962

7.  Inducible transcription of the unrearranged kappa constant region locus is a common feature of pre-B cells and does not require DNA or protein synthesis.

Authors:  K J Nelson; D E Kelley; R P Perry
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

8.  Recombination between immunoglobulin variable region gene segments is enhanced by transcription.

Authors:  T K Blackwell; M W Moore; G D Yancopoulos; H Suh; S Lutzker; E Selsing; F W Alt
Journal:  Nature       Date:  1986 Dec 11-17       Impact factor: 49.962

9.  In vitro splicing of kappa immunoglobulin precursor mRNA.

Authors:  D E Lowery; B G Van Ness
Journal:  Mol Cell Biol       Date:  1987-04       Impact factor: 4.272

10.  Establishment and characterization of BALB/c lymphoma lines with B cell properties.

Authors:  K J Kim; C Kanellopoulos-Langevin; R M Merwin; D H Sachs; R Asofsky
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

View more
  15 in total

1.  Regulation of V(D)J recombination by transcriptional promoters.

Authors:  M L Sikes; C C Suarez; E M Oltz
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

2.  Immunoglobulin kappa enhancers are differentially regulated at the level of chromatin structure.

Authors:  Barbara S Nikolajczyk; Sylvia H Sardi; Joseph R Tumang; Lisa M Ganley-Leal
Journal:  Mol Immunol       Date:  2007-03-26       Impact factor: 4.407

3.  Octamer independent activation of transcription from the kappa immunoglobulin germline promoter.

Authors:  A Prabhu; D P O'Brien; G L Weisner; R Fulton; B Van Ness
Journal:  Nucleic Acids Res       Date:  1996-12-01       Impact factor: 16.971

4.  Coordinate transcription and V(D)J recombination of the kappa immunoglobulin light-chain locus: NF-kappaB-dependent and -independent pathways of activation.

Authors:  D P O'Brien; E M Oltz; B G Van Ness
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

5.  A potential role for Elf-1 in terminal transferase gene regulation.

Authors:  P Ernst; K Hahm; L Trinh; J N Davis; M F Roussel; C W Turck; S T Smale
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

6.  Selective synergy of immunoglobulin enhancer elements in B-cell development: a characteristic of kappa light chain enhancers, but not heavy chain enhancers.

Authors:  R Fulton; B van Ness
Journal:  Nucleic Acids Res       Date:  1994-10-11       Impact factor: 16.971

7.  Targeted overexpression of an activated N-ras gene results in B-cell and plasma cell lymphoproliferation and cooperates with c-myc to induce fatal B-cell neoplasia.

Authors:  Michael A Linden; Nicole Kirchhof; Cathy S Carlson; Brian G Van Ness
Journal:  Exp Hematol       Date:  2011-11-23       Impact factor: 3.084

8.  A developmentally modulated chromatin structure at the mouse immunoglobulin kappa 3' enhancer.

Authors:  M C Roque; P A Smith; V C Blasquez
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

9.  Novel targeted deregulation of c-Myc cooperates with Bcl-X(L) to cause plasma cell neoplasms in mice.

Authors:  Wan Cheung Cheung; Joong Su Kim; Michael Linden; Liangping Peng; Brian Van Ness; Roberto D Polakiewicz; Siegfried Janz
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

10.  An AP1 binding site upstream of the kappa immunoglobulin intron enhancer binds inducible factors and contributes to expression.

Authors:  J T Schanke; A Marcuzzi; R P Podzorski; B Van Ness
Journal:  Nucleic Acids Res       Date:  1994-12-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.